Oral Contraceptive articles & resources on Made-in-China.com

Afaxys Pharmaceuticals, a Division of Afaxys, Has Introduced New Generic

Jul 26, 2013

Afaxys Pharmaceuticals, a division of Afaxys, has introduced new generic, oral contraceptive Lyza (Norethindrone Tablets USP, 0.35mg) indicated for the prevention of pregnancy in women. The generic contraceptive Lyza is available only to ...

Tags: Afaxys, Pharmaceuticals

The Company Expects to Make The Product Available in Early August 2013.

May 14, 2013

Warner Chilcott has announced US FDA approval of norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate tablets, new oral contraceptive. The company expects to make the product available in early August 2013. ...

Tags: Warner Chilcott, Oral Contraceptive

FDA Has Approved Warner Chilcott's New Oral Contraceptive Minastrin 24 FE

Apr 24, 2013

The US Food and Drug Administration (FDA) has approved Warner Chilcott's new oral contraceptive MINASTRIN 24 FE. MINASTRIN 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) is indicated for use by ...

Tags: FDA, Warner Chilcott Oral Contraceptive Medication

The US FDA Has Approved Teva Pharmaceutical Industries' New Drug Application

Apr 2, 2013

The US FDA has approved Teva Pharmaceutical Industries' new drug application (NDA) for Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets as oral contraceptives. Quartette, designed as next generation of extended ...

Tags: Health, Medicine, oral contraceptives

FDA Has Issued Marketing Approval for Oral Contraceptive Medication

Jan 24, 2013

The US FDA has issued marketing approval for Lupin Pharmaceuticals' Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1mg / 0.02mg, the combined oral contraceptive. Levonorgestrel and Ethinyl Estradiol Tablets are the generic equivalent ...

Tags: FDA, Oral Contraceptive Medication, Lupin Pharmaceuticals

Teva Women's Health Has Announced FDA Acceptance of Its Quartette NDA

Dec 7, 2012

Teva Women's Health, a US-based subsidiary of Teva Pharmaceutical Industries, has announced FDA acceptance of its Quartette new drug application (NDA). The company is seeking approval to manufacture and market Quartette ...

Tags: ethinyl estradiol tablets, market Quartette, contraceptive products

Glenmark Generics Has Announced a Consumer-Level Recall

Dec 3, 2012

Glenmark Generics has announced a consumer-level recall of seven lots of Norgestimate and Ethinyl Estradiol tablets USP, 0.18mg/0.035mg, 0.215mg/0.035mg, 0.25mg/0.035mg, because of packaging error. Select blisters were rotated 180 ...

Tags: Recall, packaging error, medical product

Lupin Pharmaceuticals Has Received Final Approval for Kurvelo Tablets From FDA

Oct 22, 2012

India-based Lupin's subsidiary Lupin Pharmaceuticals has received final approval for Kurvelo tablets from the US Food and Drugs Administration (FDA) to market a generic version of Teva Nordette tablets. The tablet, which is the AB-rated ...

Tags: Medicine, FDA

Oral Contraceptive

Related Products